• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝苯地平两种给药方案用于早产管理:一项随机对照试验

Two dose regimens of nifedipine for management of preterm labor: a randomized controlled trial.

作者信息

Nassar Anwar H, Abu-Musa Antoine A, Awwad Johnny, Khalil Ali, Tabbara Jad, Usta Ihab M

机构信息

Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut, Lebanon.

出版信息

Am J Perinatol. 2009 Sep;26(8):575-81. doi: 10.1055/s-0029-1220780. Epub 2009 Apr 27.

DOI:10.1055/s-0029-1220780
PMID:19399705
Abstract

We compared two dose regimens of tocolytic oral nifedipine. Women with singleton pregnancies admitted in preterm labor (24 to 34 weeks) were randomized to high-dose (HD) nifedipine ( N = 49; 20 mg loading dose, repeated in 30 minutes, daily 120 to 160 mg slow-release nifedipine for 48 hours followed by 80 to 120 mg daily until 36 weeks) or low-dose (LD) nifedipine ( N = 53; 10 mg, up to four doses every 15 minutes, daily 60 to 80 mg slow-release nifedipine for 48 hours followed by 60 mg daily until 36 weeks). Uterine quiescence at 48 hours (primary outcome); delivery at 48 hours, 34 and 37 weeks; and recurrent preterm labor were similar. Gestational age at delivery was higher in HD (36.0 +/- 2.8 versus 34.7 +/- 3.7 weeks, P = 0.049). Rescue treatment was needed more in LD (24.5 versus 50.9%, odds ratio = 0.3; 95% confidence interval 0.1 to 0.7). Maternal adverse effects, birth weight, intensive care nursery admission, and composite neonatal morbidity were similar. However, neonatal mechanical ventilation was needed less and nursery stay was shorter in HD. HD nifedipine does not seem to have an advantage over LD in achieving uterine quiescence at 48 hours. Further studies should address the optimal dose and formulation of tocolytic nifedipine.

摘要

我们比较了口服硝苯地平用于保胎治疗的两种剂量方案。将单胎妊娠且发生早产(24至34周)的女性随机分为高剂量(HD)硝苯地平组(N = 49;负荷剂量20 mg,30分钟后重复给药,每日给予120至160 mg缓释硝苯地平,持续48小时,随后每日80至120 mg直至孕36周)或低剂量(LD)硝苯地平组(N = 53;10 mg,每15分钟最多给药4次,每日给予60至80 mg缓释硝苯地平,持续48小时,随后每日60 mg直至孕36周)。48小时时的子宫静息状态(主要结局);48小时、34周和37周时的分娩情况;以及复发性早产情况相似。HD组的分娩孕周更高(36.0±2.8周对34.7±3.7周,P = 0.049)。LD组需要更多的补救治疗(24.5%对50.9%,优势比 = 0.3;95%置信区间0.1至0.7)。母体不良反应、出生体重、新生儿重症监护病房入住率和综合新生儿发病率相似。然而,HD组新生儿机械通气需求较少且住院时间较短。HD硝苯地平在48小时达到子宫静息方面似乎并不比LD有优势。进一步的研究应探讨保胎用硝苯地平的最佳剂量和剂型。

相似文献

1
Two dose regimens of nifedipine for management of preterm labor: a randomized controlled trial.硝苯地平两种给药方案用于早产管理:一项随机对照试验
Am J Perinatol. 2009 Sep;26(8):575-81. doi: 10.1055/s-0029-1220780. Epub 2009 Apr 27.
2
Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial.硫酸镁与硝苯地平用于早产急性保胎治疗的比较:一项随机对照试验
Obstet Gynecol. 2007 Jul;110(1):61-7. doi: 10.1097/01.AOG.0000269048.06634.35.
3
Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial.硝苯地平与利托君治疗早产:一项随机多中心试验
Obstet Gynecol. 1997 Aug;90(2):230-4. doi: 10.1016/S0029-7844(97)00182-8.
4
Safety and efficacy of oral nifedipine versus terbutaline injection in preterm labor.口服硝苯地平与特布他林注射液用于早产治疗的安全性和有效性比较
J Med Assoc Thai. 2007 Nov;90(11):2461-9.
5
Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.硝苯地平抑制宫缩治疗双胎妊娠复发性早产的管理
Am J Perinatol. 2008 Oct;25(9):555-60. doi: 10.1055/s-0028-1085622. Epub 2008 Sep 4.
6
An examination of the clinical benefits and cost-effectiveness of tocolytic replacement following recurrent preterm labor.探讨复发性早产分娩后保胎药物替换的临床获益和成本效益。
Am J Perinatol. 2010 Jan;27(1):53-9. doi: 10.1055/s-0029-1241734. Epub 2009 Oct 12.
7
Calcium channel blockers for the management of preterm birth: a review.钙通道阻滞剂在早产管理中的应用:综述。
Am J Perinatol. 2011 Jan;28(1):57-66. doi: 10.1055/s-0030-1262512. Epub 2010 Jul 16.
8
Atosiban and nifedipine in acute tocolysis: a comparative study.阿托西班与硝苯地平用于急性宫缩抑制:一项对比研究。
Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):129-34. doi: 10.1016/j.ejogrb.2005.12.010. Epub 2006 Jan 30.
9
Nifedipine versus ritodrine for suppression of preterm labor. Comparison of their efficacy and secondary effects.硝苯地平与利托君用于抑制早产。两者疗效及副作用比较。
Eur J Obstet Gynecol Reprod Biol. 2006 Aug;127(2):204-8. doi: 10.1016/j.ejogrb.2005.10.020. Epub 2005 Nov 28.
10
Tocolytic effectiveness of nifedipine versus ritodrine and follow-up of newborns: a randomised controlled trial.硝苯地平与利托君的宫缩抑制效果及新生儿随访:一项随机对照试验
Acta Obstet Gynecol Scand. 2008;87(3):340-5. doi: 10.1080/00016340801913189.

引用本文的文献

1
Effectiveness of nifedipine in threatened preterm labor: a randomized trial.硝苯地平在先兆早产中的有效性:一项随机试验。
Int J Womens Health. 2018 Jun 15;10:317-323. doi: 10.2147/IJWH.S159062. eCollection 2018.
2
Calcium channel blockers for inhibiting preterm labour and birth.用于抑制早产和分娩的钙通道阻滞剂。
Cochrane Database Syst Rev. 2014 Jun 5;2014(6):CD002255. doi: 10.1002/14651858.CD002255.pub2.
3
Calcium channel blockers as tocolytics: principles of their actions, adverse effects and therapeutic combinations.
钙通道阻滞剂作为保胎药:作用原理、不良反应和治疗组合。
Pharmaceuticals (Basel). 2013 May 23;6(6):689-99. doi: 10.3390/ph6060689.
4
Tocolytic therapy for preterm delivery: systematic review and network meta-analysis.早产治疗的保胎疗法:系统评价和网络荟萃分析。
BMJ. 2012 Oct 9;345:e6226. doi: 10.1136/bmj.e6226.